Modern Diagnostic & Research Centre Limited
BSE: MDRC · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Modern Diagnostic & Research Centre Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Modern Diagnostic and Research Centre Limited (MDRC) is a prominent Indian healthcare provider specialising in diagnostic and pathological testing. The company operates a network of centres offering advanced imaging, clinical chemistry, and molecular diagnostics, with a strong focus on high-end technology and quality certifications.
Business Model
MDRC generates revenue by providing diagnostic services to patients through its network of laboratories and collection points. Its business model leverages high-end medical technology and quality accreditations to capture demand for both routine and specialised diagnostic testing.
Management Commentary
Management emphasises the expansion of laboratory infrastructure and the integration of digital health offerings to better serve the growing patient base. The company remains committed to maintaining high quality standards such as NABL and NABH across its service network.
Growth Outlook
Growth is driven by the ongoing expansion of the company's laboratory infrastructure and the development of digital health solutions. Increased demand for preventive and diagnostic healthcare services in the North India region provides a robust foundation for future scaling.
Key Risks
- Regulatory Compliance. Changes in healthcare regulations or the loss of critical quality certifications like NABL and NABH could negatively impact operations.
- Geographic Concentration. The company's heavy reliance on the Delhi NCR region exposes it to localised economic downturns or intensified regional competition.
- Technological Obsolescence. Failure to continuously invest in and upgrade diagnostic equipment may lead to a loss of competitive advantage in the high-end testing market.
- Intense Competition. The diagnostic sector in India is highly fragmented and competitive, which may exert pressure on pricing and profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Modern Diagnostic & Research Centre Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Modern Diagnostic & Research Centre LimitedMDRC | ₹86 Cr | — | — | — | 15.2% | — | — | — |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,830 Cr | 18.76 | 8.80 | 10.2% | 32.5% | 10.5% | 13.3% | -28.5% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,772 Cr | 48.60 | 16.73 | 22.5% | 32.7% | 15.8% | 18.6% | +14.0% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,237 Cr | 20.61 | 14.59 | 41.9% | 58.0% | 21.2% | 26.3% | +0.5% |
One Global Service Provider LimitedONEGLOBAL | ₹1,068 Cr | — | — | — | 19.0% | — | — | +114.9% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹886 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Modern Diagnostic & Research Centre Limited
BSE: MDRC · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Modern Diagnostic & Research Centre Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Modern Diagnostic and Research Centre Limited (MDRC) is a prominent Indian healthcare provider specialising in diagnostic and pathological testing. The company operates a network of centres offering advanced imaging, clinical chemistry, and molecular diagnostics, with a strong focus on high-end technology and quality certifications.
Business Model
MDRC generates revenue by providing diagnostic services to patients through its network of laboratories and collection points. Its business model leverages high-end medical technology and quality accreditations to capture demand for both routine and specialised diagnostic testing.
Management Commentary
Management emphasises the expansion of laboratory infrastructure and the integration of digital health offerings to better serve the growing patient base. The company remains committed to maintaining high quality standards such as NABL and NABH across its service network.
Growth Outlook
Growth is driven by the ongoing expansion of the company's laboratory infrastructure and the development of digital health solutions. Increased demand for preventive and diagnostic healthcare services in the North India region provides a robust foundation for future scaling.
Key Risks
- Regulatory Compliance. Changes in healthcare regulations or the loss of critical quality certifications like NABL and NABH could negatively impact operations.
- Geographic Concentration. The company's heavy reliance on the Delhi NCR region exposes it to localised economic downturns or intensified regional competition.
- Technological Obsolescence. Failure to continuously invest in and upgrade diagnostic equipment may lead to a loss of competitive advantage in the high-end testing market.
- Intense Competition. The diagnostic sector in India is highly fragmented and competitive, which may exert pressure on pricing and profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on Modern Diagnostic & Research Centre Limited and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026